Table 3.
Relationship between lncRNA SNHG5 expression and the clinicopathological characteristics of CRC patients
| |
|
lncRNA SNHG5 expression |
|
|
|
|---|---|---|---|---|---|
| Characteristics | Number (n = 40) | Low | High | χ2 | P value |
| Sex | |||||
| Male | 23 | 9 | 14 | 2.5575 | 0.1098 |
| Female | 17 | 11 | 6 | ||
| Age(years) | |||||
| < 60 | 19 | 12 | 7 | 2.5063 | 0.1134 |
| ≥ 60 | 21 | 8 | 13 | ||
| Lymph node metastasis | |||||
| Present | 24 | 8 | 16 | 6.6667 | 0.0098 |
| Absent | 16 | 12 | 4 | ||
| Tumor size (cm) | |||||
| < 5 | 12 | 7 | 5 | 0.4762 | 0.4902 |
| ≥ 5 | 28 | 13 | 15 | ||
| Histological grade | |||||
| Well or moderate | 18 | 10 | 8 | 0.4040 | 0.5250 |
| Poor | 22 | 10 | 12 | ||
| Tumor stage | |||||
| T1 – T2 | 16 | 9 | 7 | 0.4167 | 0.5186 |
| T3 – T4 | 24 | 11 | 13 | ||
| Differentiation | |||||
| Well/moderate | 19 | 12 | 7 | 2.5063 | 0.1134 |
| Poor | 21 | 8 | 13 | ||